Rebekkah Carney, MIM, Human Factors Investigator, Healthcare Research and Analytics (HRA), a company of the Agency Network at MJH Life Sciences, Brand Insights Contributor

Articles by Rebekkah Carney, MIM, Human Factors Investigator, Healthcare Research and Analytics (HRA), a company of the Agency Network at MJH Life Sciences, Brand Insights Contributor

Better marketing by design: humanizing drug delivery systems

ByRebekkah Carney, MIM, Human Factors Investigator, Healthcare Research and Analytics (HRA), a company of the Agency Network at MJH Life Sciences, Brand Insights Contributor

April 18th 2022

Brand Insights - Thought Leadership | Paid Program

Latest Updated Articles

Better marketing by design: humanizing drug delivery systems
April 18th 2022

Trending on PharmExec

Roundup: Novartis & Abogen Enter Licensing and Option Agreement, AstraZeneca and Daiichi Sankyo Enter Clinical Collaboration with Summit Therapeutics

Foghorn Therapeutics & Eli Lilly Halt Fhd-909 Development Following Phase I Data

How a Shift Towards Oral Medications Impacts GLP-1s

Pharmaceutical Executive Daily: Foghorn Therapeutics & Eli Lilly Discontinue Development of FHD-909

The Most Surprising Development in GLP-1s